Sciton Forms New Business Unit and Launches diVaTM January 2016; A Breakthrough Hybrid Fractional Laser for the Treatment of Vaginal Tissue

PALO ALTO, Calif.–(BUSINESS WIRE)–Sciton, a leading manufacturer of light and laser devices in the medical
and aesthetic industry, announced today the formation of a new, separate
business unit within the company. The Women’s Health Group (WHG), led by
Aaron Burton, General Manager, will focus solely on products that
provide solutions for women. Sciton anticipates quick growth in this
business unit and plans to increase staffing needs, respectively.

Long known for providing a suite of best-in-class energy-based
technologies on its singular expandable platform, the JOULETM,
Sciton realized the need to expand its applications for treating women’s
health because the majority of end patients are women going through
various life milestones who would like to address health as well as
aesthetic issues.

“As we develop our next generation of products, we regularly correspond
with long-time users and recognize the need to apply our existing
technologies to this particular space. Women have unique feminine issues
that refined energy-based solutions can address, and it clearly makes
sense for us to complement our current portfolio with a new suite of
products focused on women,” said CEO Jim Hobart.

Sciton is also premiering its first product for the improvement of
vaginal tissue. diVa, the first Hybrid Fractional Laser (HFLTM)
for laser vaginal therapy, will be launched January 2016. diVa utilizes
the revolutionary HFL technology developed for HaloTM, the
world’s first and only hybrid fractional laser, to provide independent
levels of ablation and coagulation, as well as varying levels of
density. This allows the provider to customize the treatment based on
the patient’s desired results.

Speaking on the need in the marketplace for a laser like diVa, Dr.
Lionel Meadows, Fellow of the American College of Obstetrics and
Gynecology, said, “Many patients young and old ask me daily if there is
a nonsurgical, non-hormonal solution to improve the quality of their
vaginal tissue. I can now recommend diVa.”

diVa is safe and suitable for women of all ages who may be interested in
a resurfacing treatment to improve the quality of their vaginal tissue.
The ergonomic, automated design of the handpiece allows for a full
treatment of the vaginal canal in approximately three to five minutes,
with little to no discomfort to the patient and increased efficiency for
the healthcare provider. “With diVa, physicians have an innovative way
to treat feminine health. We’re excited to share the new features in
diVa that exhibit Sciton’s commitment to excellence in resurfacing
technology. This product uniquely incorporates High Precision Automation
(HPA), using a refined motorized control system for the provider to
deliver very fast, consistent, and predictable treatments for every
patient. Additionally, we designed a single-use Strengthened Quartz
Dilator (SQD) to be used with each patient, which eliminates the risk of
cross-contamination and shortens downtime between treatments,” said
President Dan Negus.

diVa is available on the JOULE platform, which offers multiple modules
to treat a wide range of indications. Visit Sciton at booth #300 at AACS
or www.sciton.com/diva
to learn more about diVa.

ABOUT SCITON: Sciton is committed to providing best-in-class laser and
light solutions for medical professionals who want superior durability,
performance and value. Sciton offers high-quality medical devices for
laser-assisted lipolysis, fractional and full-coverage skin resurfacing,
hair removal, phototherapy, wrinkle reduction, treatment of vascular and
pigmented lesions, scar reduction, and acne. For more information, and a
complete listing of Sciton systems, visit www.Sciton.com.
Like Sciton on Facebook at www.facebook.com/ScitonInc
and follow Sciton on LinkedIn at www.linkedin.com/company/sciton.

Contacts

Sciton
Peggy Chung, 650-493-9155
peggy.chung@sciton.com